Yesterday was a big day in vaccine news. We learned more about how well Johnson & Johnson’s vaccine works and how safe it is. And we also learned that Moderna has a plan for tackling variants. That includes a new shot it’s sending to NIH for testing.
Also in healthcare news: What happened to Comcast Ventures, a onetime healthcare startup kingmaker, the companies gene therapy leaders may need to help fix safety issues, and Devoted Health quietly raised $380 million in 2020.
- Comcast Ventures was the independent venture arm of media giant Comcast.
- In November, Comcast moved Comcast Ventures into its business development division.
- It was a kingmaker of healthcare benefits startups in the past but may not be as active going forward.
Gene therapy leaders may need M&A to solve their safety issues. Here are the 8 companies analysts are watching.
- Gene therapies, in which healthy genes are inserted into a person’s system, are a booming biotech investment area.
- Audentes, Bluebird bio, Sarepta, and UniQure have all run into potential safety issues in the last year.
- That could spur a wave of dealmaking focused on making gene therapies safer and easier to deliver, analysts say.
Devoted Health quietly raised $380 million to gear up for fierce competition in the red-hot health-plan market for older people
- Devoted Health raised $380 million in July 2020, Insider has learned.
- The round was led by Uprising.
- The round will fund Devoted’s growth as competition for Medicare Advantage members heats up.
More stories we’re reading:
- One Medical let ineligible people get vaccines, prompting the Washington State Department of Health to stop sending it vaccines (NPR)
- There’s a clear, scientific path to safely reopening schools. The real barrier now is politics. (Insider)
- What happens with telemedicine when we’re not stuck at home (Protocol)
- Startups trying to change the way healthcare is paid for pulled in a record $3.6 billion in 2020. Meet the top 8 VC firms that placed the most bets. (Insider)